NEW HAVEN, CT, UNITED STATES, February 24, 2026 /EINPresswire.com/ -- Yale Associate Research Scientist Investigates ...

Novo Nordisk started the GLP-1 craze more than five years ago with injectable Ozempic. Five years later, the company's taken ...

Researchers have quantified the role of obesity in common long-term conditions, showing for the first time the effect of losing weight in preventing multiple diseases. Conditions that often occur ...

LONDON, Feb 2 (Reuters) - The long-held Wall Street expectation that the global market for obesity drugs would reach $150 billion in the next decade is looking a lot less certain with U.S. prices ...

Adult obesity in the United States has gone up over the past 30 years and more increases are expected in the next decade, according to a new study. In the study, published Tuesday, Jan. 28, in JAMA, ...

For decades, the world has watched Oprah Winfrey’s very public battle with her weight, as she yo-yoed between sizes, inspiring admiration with every pound she lost and ridicule when she gained it back ...

Researchers forecast the national prevalence of obesity to rise from 42.5% of the U.S. adult population in 2022 to 46.9% by 2035, according to a study published Jan. 28 in JAMA. In the U.S., ...

Between 2013 and 2022, obesity surged across the United States, and, while there has been a notable drop in levels since a peak of almost 40 percent in 2022, some states have still seen dramatic ...

Please provide your email address to receive an email when new articles are posted on . The prevalence of obesity was 75.2% among adults in the U.S. when new criteria proposed by The Lancet Diabetes & ...

Eli Lilly has returned to Nimbus Therapeutics for another metabolic collaboration, this time focused on the red-hot R&D space of oral obesity therapies. The latest partnership will see Lilly pass ...

Wegovy is an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. It will soon be available in pill form.

Eli Lilly said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking Wegovy and Zepbound injections in a late-stage trial ...